Literature DB >> 10785330

Economic aspects of the control of classical swine fever outbreaks in the European Union.

H W Saatkamp1, P B Berentsen, H S Horst.   

Abstract

A framework for assessing the economic impact of classical swine fever (CSF) is presented, including an analysis of direct and indirect costs. Direct costs are divided into calculated costs, expenditure on control measures (payable costs) and costs due to financial transfers. The economic impact of current control strategies is described using practical examples. In most cases, the largest part of the direct costs is associated with transport standstill measures, of which approximately 45% are calculated costs. Alternative strategies, still based on non-vaccination offer a potential for reducing these costs. Various economic aspects of emergency vaccination are described using as an example, a hypothetical optimistic CSF case. In order to explore the impact of applying emergency vaccination using marker vaccines, additional research is required using simulation modelling. This research should include an assessment of risk and uncertainty with respect to calculating the epidemiological impact and the direct costs.

Entities:  

Mesh:

Year:  2000        PMID: 10785330     DOI: 10.1016/s0378-1135(00)00147-4

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  14 in total

1.  Foreign animal disease outbreaks, the animal welfare implications for Canada: risks apparent from international experience.

Authors:  Terry L Whiting
Journal:  Can Vet J       Date:  2003-10       Impact factor: 1.008

2.  Time to critical overcrowding of Manitoba swine barns in the event of restriction on animal movement.

Authors:  Leeanne L Bargen; Terry L Whiting
Journal:  Can Vet J       Date:  2002-11       Impact factor: 1.008

3.  Isolation and characterization of the promoter and partial enhancer region of the porcine inter-alpha-trypsin inhibitor heavy chain 4 gene.

Authors:  Niamh Harraghy; Timothy J Mitchell
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

Review 4.  Why must we rush to bury our dead (pigs): The option of excarnation by exposure.

Authors:  Terry L Whiting
Journal:  Can Vet J       Date:  2021-12       Impact factor: 1.008

5.  Serological Hendra Virus Diagnostics Using an Indirect ELISA-Based DIVA Approach with Recombinant Hendra G and N Proteins.

Authors:  Anne Balkema-Buschmann; Kerstin Fischer; Leanne McNabb; Sandra Diederich; Nagendrakumar Balasubramanian Singanallur; Ute Ziegler; Günther M Keil; Peter D Kirkland; Maren Penning; Balal Sadeghi; Glenn Marsh; Jennifer Barr; Axel Colling
Journal:  Microorganisms       Date:  2022-05-25

6.  Complete sequence of a subgroup 3.4 strain of classical swine fever virus from Taiwan.

Authors:  Yu-Ju Lin; Maw-Sheng Chien; Ming-Chung Deng; Chin-Cheng Huang
Journal:  Virus Genes       Date:  2007-08-25       Impact factor: 2.332

7.  Time-calibrated phylogenomics of the classical swine fever viruses: genome-wide bayesian coalescent approach.

Authors:  Taehyung Kwon; Sook Hee Yoon; Kyu-Won Kim; Kelsey Caetano-Anolles; Seoae Cho; Heebal Kim
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

8.  Modeling Classical Swine Fever Outbreak-Related Outcomes.

Authors:  Shankar Yadav; Nicole J Olynk Widmar; Hsin-Yi Weng
Journal:  Front Vet Sci       Date:  2016-02-03

9.  Quantitative approach for the risk assessment of African swine fever and Classical swine fever introduction into the United States through legal imports of pigs and swine products.

Authors:  Diana María Herrera-Ibatá; Beatriz Martínez-López; Darla Quijada; Kenneth Burton; Lina Mur
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

10.  Epidemiological and Economic Evaluation of Alternative On-Farm Management Scenarios for Ovine Footrot in Switzerland.

Authors:  Dana Zingg; Sandro Steinbach; Christian Kuhlgatz; Matthias Rediger; Gertraud Schüpbach-Regula; Matteo Aepli; Gry M Grøneng; Salome Dürr
Journal:  Front Vet Sci       Date:  2017-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.